The use of bioinformatics for identifying class II-restricted T-cell epitopes

被引:66
作者
Bian, HJ [1 ]
Reidhaar-Olson, JF [1 ]
Hammer, J [1 ]
机构
[1] Hoffmann La Roche Inc, Sect Bioinformat Genet & Genom, Nutley, NJ 07110 USA
关键词
TEPITOPE; human leukocyte antigen class II; epitope prediction; vaccinome;
D O I
10.1016/S1046-2023(02)00352-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An important step in the design of subunit vaccines is the identification of promiscuous T helper cell epitopes in sets of disease-specific gene products. Most of the epitope prediction models are based on HLA-II peptide binding, which constitutes a major bottleneck in the natural selection of epitopes. Here we describe a computer model, TEPITOPE, that enables the systematic prediction of promiscuous peptide ligands for a broad range of HLA binding specificity. We show how to apply the TEPITOPE prediction model to identify T-cell epitopes, and provide examples of its successful application in the context of oncology, allergy, and infectious and autoimmune diseases. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 17 条
[1]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[2]   Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network [J].
Brusic, V ;
Rudy, G ;
Honeyman, M ;
Hammer, J ;
Harrison, L .
BIOINFORMATICS, 1998, 14 (02) :121-130
[3]   In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program [J].
Cochlovius, B ;
Stassar, M ;
Christ, O ;
Raddrizzani, L ;
Hammer, J ;
Mytilineos, I ;
Zöller, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (08) :4731-4741
[4]  
de Lalla C, 1999, J IMMUNOL, V163, P1725
[5]   Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis [J].
Gross, DM ;
Forsthuber, T ;
Tary-Lehmann, M ;
Etling, C ;
Ito, K ;
Nagy, ZA ;
Field, JA ;
Steere, AC ;
Huber, BT .
SCIENCE, 1998, 281 (5377) :703-706
[6]  
Hammer J, 1997, ADV IMMUNOL, V66, P67, DOI 10.1016/S0065-2776(08)60596-9
[7]   HIGH-AFFINITY BINDING OF SHORT PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES BY ANCHOR COMBINATIONS [J].
HAMMER, J ;
BELUNIS, C ;
BOLIN, D ;
PAPADOPOULOS, J ;
WALSKY, R ;
HIGELIN, J ;
DANHO, W ;
SINIGAGLIA, F ;
NAGY, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4456-4460
[8]   PEPTIDE BINDING-SPECIFICITY OF HLA-DR4 MOLECULES - CORRELATION WITH RHEUMATOID-ARTHRITIS ASSOCIATION [J].
HAMMER, J ;
GALLAZZI, F ;
BONO, E ;
KARR, RW ;
GUENOT, J ;
VALSASNINI, P ;
NAGY, ZA ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1847-1855
[9]   PROMISCUOUS AND ALLELE-SPECIFIC ANCHORS IN HLA-DR-BINDING PEPTIDES [J].
HAMMER, J ;
VALSASNINI, P ;
TOLBA, K ;
BOLIN, D ;
HIGELIN, J ;
TAKACS, B ;
SINIGAGLIA, F .
CELL, 1993, 74 (01) :197-203
[10]   PRECISE PREDICTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PEPTIDE INTERACTION BASED ON PEPTIDE SIDE-CHAIN SCANNING [J].
HAMMER, J ;
BONO, E ;
GALLAZZI, F ;
BELUNIS, C ;
NAGY, Z ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2353-2358